This inventor holds 2 USPTO granted patents and 3 published patent applications and 3 EPO patents. Top assignee: Cyclacel Pharmaceuticals, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Chris Atherton - Innovator in Pharmaceutical Chemistry
Introduction
Chris Atherton is an inventor based in Durham, GB. He is currently associated with Cyclacel Limited, a company focused on developing innovative cancer therapies. Although he has not yet been granted any patents, his work in the field of pharmaceutical chemistry is noteworthy.
Latest Patent Applications
Chris Atherton has submitted several patent applications that showcase his innovative approaches. One of his latest applications is titled "Process for the Preparation of a Pyrimidino-Diazepine Derivative." This invention outlines a method for preparing a compound through a series of steps involving the treatment of specific compounds and the isolation of isomers. Another significant application is "Crystalline Forms of Pyrimidino Diazepine Derivative," which relates to new crystalline forms exhibiting excellent anti-tumor activity. This invention also includes a pharmaceutical composition containing these crystalline forms as an active ingredient, aimed at the prevention or treatment of diseases.
Conclusion
Chris Atherton's contributions to pharmaceutical chemistry, particularly through his latest patent applications, highlight his commitment to advancing cancer treatment. His work at Cyclacel Limited positions him as a promising inventor in the field.